Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 4/2013

01-07-2013 | Original Article

Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts

Authors: Zhiyong Zeng, Chenqing Zhang, Junmin Chen

Published in: Journal of Bone and Mineral Metabolism | Issue 4/2013

Login to get access

Abstract

Cell–cell fusion is a critical step in osteoclast development, because only after osteoclasts become multinucleated can they efficiently resorb bone. Although recent studies suggest that dendritic cell-specific transmembrane protein (DC-STAMP) may play a key role in the process of fusion of mouse osteoclasts, little information has been available on the role of DC-STAMP in human osteoclasts. In this study, we screened and identified an in vitro-transcribed short-hairpin RNA targeting human DC-STAMP from four candidates and generated a lentivirus vector. Subsequent experiments indicated that this lentiviral transgenic system could effectively transfer into target human osteoclasts, at more than 80 % gene transfer efficiency at multiplicity of infection of 15, and significantly and specifically inhibited DC-STAMP expression at both mRNA and protein levels. We also found that DC-STAMP inhibition by RNAi consequently suppressed fusion and bone resorption of human osteoclasts. In conclusion, these data indicated the lentivirus-mediated RNAi was capable of efficiently suppressing DC-STAMP expression in primary human osteoclasts and inhibiting osteoclastogenesis, demonstrating an essential role of DC-STAMP in the differentiation of human osteoclasts.
Literature
1.
go back to reference Yaccoby S, Pearse RN, Johnson CL, Barlogie B, Choi Y, Epstein J (2002) Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity. Br J Haematol 116:278–290PubMedCrossRef Yaccoby S, Pearse RN, Johnson CL, Barlogie B, Choi Y, Epstein J (2002) Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity. Br J Haematol 116:278–290PubMedCrossRef
2.
go back to reference Abe M, Hiura K, Wilde J, Shioyasono A, Moriyama K, Hashimoto T, Kido S, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T (2004) Osteoclasts enhance myeloma cell growth and survival via cell–cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood 104:2484–2491PubMedCrossRef Abe M, Hiura K, Wilde J, Shioyasono A, Moriyama K, Hashimoto T, Kido S, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T (2004) Osteoclasts enhance myeloma cell growth and survival via cell–cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood 104:2484–2491PubMedCrossRef
3.
go back to reference Iwasaki R, Ninomiya K, Miyamoto K, Suzuki T, Sato Y, Kawana H, Nakagawa T, Suda T, Miyamoto T (2008) Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. Biochem Biophys Res Commun 377:899–904PubMedCrossRef Iwasaki R, Ninomiya K, Miyamoto K, Suzuki T, Sato Y, Kawana H, Nakagawa T, Suda T, Miyamoto T (2008) Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. Biochem Biophys Res Commun 377:899–904PubMedCrossRef
4.
go back to reference Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T (2005) DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202:345–351PubMedCrossRef Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T (2005) DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202:345–351PubMedCrossRef
5.
go back to reference Zeng Z, Chen J (2009) Cell–cell fusion: human multinucleated osteoclasts. Cent Eur J Biol 4:543–548CrossRef Zeng Z, Chen J (2009) Cell–cell fusion: human multinucleated osteoclasts. Cent Eur J Biol 4:543–548CrossRef
6.
go back to reference Chiu YH, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT (2011) Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res 43:685–689 Chiu YH, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT (2011) Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res 43:685–689
7.
go back to reference Laitala-Leinonen T (2005) Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systems. J Negat Results Biomed 4:5PubMedCrossRef Laitala-Leinonen T (2005) Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systems. J Negat Results Biomed 4:5PubMedCrossRef
8.
go back to reference Fukuda A, Hikita A, Wakeyama H, Akiyama T, Oda H, Nakamura K, Tanaka S (2005) Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J Bone Miner Res 20:2245–2253PubMedCrossRef Fukuda A, Hikita A, Wakeyama H, Akiyama T, Oda H, Nakamura K, Tanaka S (2005) Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J Bone Miner Res 20:2245–2253PubMedCrossRef
9.
go back to reference Kobayashi Y, Take I, Yamashita T, Mizoguchi T, Ninomiya T, Hattori T, Kurihara S, Ozawa H, Udagawa N, Takahashi N (2005) Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 280:24035–24042PubMedCrossRef Kobayashi Y, Take I, Yamashita T, Mizoguchi T, Ninomiya T, Hattori T, Kurihara S, Ozawa H, Udagawa N, Takahashi N (2005) Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 280:24035–24042PubMedCrossRef
10.
go back to reference Zeng Z, Chen J (2012) Construction and identification of eukaryotic expression vector expressing human DC-STAMP. J Fujian Med Univ 46:31–35 Zeng Z, Chen J (2012) Construction and identification of eukaryotic expression vector expressing human DC-STAMP. J Fujian Med Univ 46:31–35
11.
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef
12.
go back to reference Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature (Lond) 423:337–342CrossRef Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature (Lond) 423:337–342CrossRef
13.
go back to reference Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M (2004) Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 94:239–246PubMedCrossRef Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M (2004) Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 94:239–246PubMedCrossRef
14.
go back to reference Itonaga I, Sabokbar A, Neale SD, Athanasou NA (1999) 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. Biochem Biophys Res Commun 264:590–595PubMedCrossRef Itonaga I, Sabokbar A, Neale SD, Athanasou NA (1999) 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. Biochem Biophys Res Commun 264:590–595PubMedCrossRef
15.
go back to reference Kotake S, Yago T, Kawamoto M, Nanke Y (2012) Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial ‘human osteoclastology’. J Bone Miner Metab 30:125–135PubMedCrossRef Kotake S, Yago T, Kawamoto M, Nanke Y (2012) Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial ‘human osteoclastology’. J Bone Miner Metab 30:125–135PubMedCrossRef
16.
go back to reference Kotake S, Nanke Y, Yago T, Kawamoto M, Yamanaka H (2009) Human osteoclastogenic T cells and human osteoclastology. Arthritis Rheum 60:3158–3163PubMedCrossRef Kotake S, Nanke Y, Yago T, Kawamoto M, Yamanaka H (2009) Human osteoclastogenic T cells and human osteoclastology. Arthritis Rheum 60:3158–3163PubMedCrossRef
17.
go back to reference Hartgers FC, Vissers JL, Looman MW, van Zoelen C, Huffine C, Figdor CG, Adema GJ (2000) DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol 30:3585–3590PubMedCrossRef Hartgers FC, Vissers JL, Looman MW, van Zoelen C, Huffine C, Figdor CG, Adema GJ (2000) DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol 30:3585–3590PubMedCrossRef
18.
go back to reference Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200:941–946PubMedCrossRef Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200:941–946PubMedCrossRef
19.
go back to reference Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD (2008) siRNA, miRNA, and shRNA: in vivo applications. J Dent Res 87:992–1003PubMedCrossRef Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD (2008) siRNA, miRNA, and shRNA: in vivo applications. J Dent Res 87:992–1003PubMedCrossRef
20.
go back to reference Kasim V, Taira K, Miyagishi M (2006) Screening of siRNA target sequences by using fragmentized DNA. J Gene Med 8:782–791PubMedCrossRef Kasim V, Taira K, Miyagishi M (2006) Screening of siRNA target sequences by using fragmentized DNA. J Gene Med 8:782–791PubMedCrossRef
21.
go back to reference Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA 101:1892–1897PubMedCrossRef Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA 101:1892–1897PubMedCrossRef
22.
go back to reference Chu K, Cornetta KG, Econs MJ (2008) Efficient and stable gene expression into human osteoclasts using an HIV-1-based lentiviral vector. DNA Cell Biol 27:315–320PubMedCrossRef Chu K, Cornetta KG, Econs MJ (2008) Efficient and stable gene expression into human osteoclasts using an HIV-1-based lentiviral vector. DNA Cell Biol 27:315–320PubMedCrossRef
Metadata
Title
Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts
Authors
Zhiyong Zeng
Chenqing Zhang
Junmin Chen
Publication date
01-07-2013
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 4/2013
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-013-0434-0

Other articles of this Issue 4/2013

Journal of Bone and Mineral Metabolism 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.